Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk
Clinical trial NCT05297617 · RECRUITING
Trial details
- NCT number
- NCT05297617
- Sponsor
- UNICANCER
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2030-11-12
- Enrollment
- 696
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.